AbbVie's Skyrizi nabs psoriatic arthritis nod, its 2nd, shortly after Rinvoq | FiercePharma
AbbVie on Twitter: "Tom Hudson joined AbbVie to help bring innovative treatments to patients faster. Learn more about his vision for the future of cancer treatment via @CancerResearch: https://t.co/XdfWDnDzpd https://t.co/QM87UDuA0j" / Twitter
Thomas Hudson's email & phone | AbbVie's Senior Vice Research and Development and Chief Scientific Officer email
Learn more about AbbVie, its West Coast R&D efforts in Oncology and its Corporate Ventures Arm - MBC BioLabs
AbbVie: ChemBeads, Improving Artificial Intelligence Through Human Ingenuity
Striving to Outsmart Cancer Together | AbbVie
Our R&D Leaders - Our Science | AbbVie
Strategic Advisory Board
AbbVie and Google-backed Calico re-commit to anti-ageing mission
AbbVie on Twitter: "#DYK we partner with others to give science an edge against tough diseases like #COVID19 and #cancer? This lets us “remain creative, nimble and innovative as we develop therapies
AbbVie в Twitter: "Collaboration matters now more than ever. R&D leader Tom Hudson shared how the collective expertise of the scientific community will help us overcome #COVID19 and transform the future of
Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe | FiercePharma
AbbVie on Twitter: "Tom Hudson, AbbVie Chief Scientific Officer How it started: How it's going: https://t.co/4o1roia3Yt" / Twitter
AbbVie developing COVID-19 therapy | Crain's Chicago Business
AbbVie hits go on $1B re-upped Calico deal as the Google life science spinout continues I-O, neuro push | FierceBiotech
AbbVie signs immunotherapy deal with I-Mab worth $2bn - Pharmaceutical Technology
AbbVie Careers - Tom Hudson has six sisters, including a twin sister, who were all drawn to science careers. “There wasn't any pressure to be in this field,” Tom says. “My dad
AbbVie on Twitter: "Renowned researcher, Tom Hudson, discusses how his work on the Human Genome Project influences his cancer research: https://t.co/NE2p8hD4EE https://t.co/XxW1OwIa8C" / Twitter
AbbVie Makes Large Investment in Regenxbio's Gene Therapy for Retinal Diseases - Eyewire+
AbbVie Helps to Advance Gene Therapy for Chronic Retinal Diseases
